Hospitalizations

AOD Hospitalizations in Los Angeles County

From 2015 to 2024, there were 1,423,234 hospitalizations in Los Angeles County (LAC) that listed any alcohol or other drug abuse, dependence, use, or poisoning as a diagnosis (AOD-related). AOD-related hospitalizations increased 18% from 2020 to 2024. In 2024, the annual total number of AOD-related hospitalizations was 156,377 cases (Figure 1).

From 2015-2024, a total of 236,914 cases, or 17% of AOD-related hospitalizations, listed AOD abuse, dependence, use, or poisoning as the principal diagnosis (primary). Primary AOD hospitalizations increased 13% from 2020 to 2024. In 2024, the annual total number of primary AOD hospitalizations was 24,687 cases (Figure 2).

Demographics of AOD Hospitalizations

Any Mention

In 2015-2024, adults aged 45-64 (36%) accounted for the largest proportion of AOD-related hospitalizations, followed by those aged 65+ (24%), aged 35-44 (14%), aged 26-34 (13%), and aged 18-25 (8%) (Figure 3). AOD-related hospitalizations increased by 13% among adults aged 45-64, and increased by 20% among older adults aged 65+ from 2020 to 2024 (Figure 4).

Primary

In 2015-2024, adults aged 45-64 (39%) accounted for the largest proportion of primary AOD hospitalizations, followed by those aged 35-44 (19%), aged 26-34 (17%), and aged 65+ (14%) (Figure 5). From 2005-2022, adults aged 45-64 had by far the most annual primary AOD hospitalizations of all age groups over the past decade. From 2015 to 2024, while primary AOD hospitalizations decreased 34% among young adults aged 18-25, primary AOD hospitalizations increased 49% among adults 26-34 and increased 47% among adults 35-44 (Figure 6).

Any Mention

Males accounted for the majority (61%) of AOD-related hospitalizations from 2015-2024 (Figure 7). The gender disparity remained stable over the past decade (Figure 8).

Primary

Among primary AOD hospitalizations, males accounted for two-thirds (67%) from 2015-2024. The gender disparity increased over the past decade, with males accounting for 64% of primary AOD hospitalizations in 2015 to 69% in 2024 (Figures 9-10).

Any Mention

From 2019-2024 in LAC, Hispanic/Latinos (40%) accounted for the largest proportions of AOD-related hospitalizations, followed by Whites (31%), and Blacks (16%). Hispanic/Latinos and Whites trended in opposite directions over the past decade, in which the proportion of AOD-related hospitalizations for Hispanic/Latinos increased from 34% in 2015 to 42% in 2024, while the proportion for Whites decreased from 38% to 28% (Figures 11-12). 

Primary

The opposing trends were similarly observed and more pronounced for primary AOD hospitalizations, with the proportion of primary AOD hospitalizations for Hispanic/Latinos increasing from 36% to 48% in 2024, while that for Whites decreased from 46% to 30% from 2015 to 2024 (Figures 13-14).

Economic Burden of AOD

Hospital Days

In LAC from 2015-2024, patients hospitalized for AOD-related conditions stayed in the hospital for a total of 9.2 million hospital days, of which 1.2 million hospital days were for a primary AOD condition. In 2024, the average length of stay was 6.4 days for AOD-related hospitalizations, and was 5.2 days for primary AOD hospitalizations.

Hospital Spending

From 2015-2024, the average hospital charge for AOD-related conditions was $112,607, while the average hospital charge for primary AOD conditions was $67,608. Each primary AOD hospitalization in LAC increased from $51,878 in 2015 to $77,279 in 2024. 

Total spending for all AOD-related hospitalizations increased from $9.9 billion in 2015 to $18.5 billion 2024. For primary AOD hospitalizations, total spending increased from $1.2 billion in 2015 to $1.9 billion in 2024 (Figure 15).

Notes: Hospitalizations for less than 1 day were counted as having a length of stay of 1 day. All costs are adjusted for inflation to 2024 US dollars.

References

Department of Health Care Access and Information (HCAI), 2015-2024. Nonpublic Inpatient Discharge and Emergency Department data 2015-2024. California Department of Public Health.